QQ客服 官方微博 反馈留言

	Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer
	Wang, M.; Hao, F-Y.; Wang, J-G.; Xiao, W.
刊名	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
	2014
卷号	18期号:18页码:2648-2654
关键词	Lung adenocarcinoma Group IIa secretory phospholipase A2 Immunohistochemistry Prognosis
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4797605
专题	山东大学
作者单位	1.Shandong Univ, Qilu Hosp, Resp Med, Jinan 250100, Peoples R China. 2.Qingdao Univ, Affiliated Hosp, Resp Med, Qingdao
推荐引用方式 GB/T 7714	Wang, M.,Hao, F-Y.,Wang, J-G.,et al. Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,2014,18(18):2648-2654.
APA	Wang, M.,Hao, F-Y.,Wang, J-G.,&Xiao, W..(2014).Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,18(18),2648-2654.
MLA	Wang, M.,et al."Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer".EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 18.18(2014):2648-2654.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。